[{"id":"2fbb65a4-a780-422e-b302-4dd9315ffcc1","acronym":"","url":"https://clinicaltrials.gov/study/NCT05145569","created_at":"2024-06-01T04:17:55.472Z","updated_at":"2024-07-02T16:35:00.527Z","phase":"Phase 2","brief_title":"Antitumor Activity of Neoadjuvant Chemotherapy With or Without HCW9218 in Metastatic Advanced Stage Ovarian Cancer","source_id_and_acronym":"NCT05145569","lead_sponsor":"Haider Mahdi","biomarkers":" CD8","pipe":"","alterations":" ","tags":["CD8"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e carboplatin • paclitaxel • HCW9218"],"overall_status":"Recruiting","enrollment":" Enrollment 33","initiation":"Initiation: 05/10/2024","start_date":" 05/10/2024","primary_txt":" Primary completion: 05/31/2026","primary_completion_date":" 05/31/2026","study_txt":" Completion: 01/31/2028","study_completion_date":" 01/31/2028","last_update_posted":"2024-05-29"}]